Join
Live feed
·
PRReleasevia Quantisnow
Adial Pharmaceuticals Inc logo

Adial Pharmaceuticals Reaches Full Enrollment Target for ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients With Alcohol Use Disorder

ByQuantisnow·Wall Street's wire, on your screen.
ADIL· Adial Pharmaceuticals Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADIL (Adial Pharmaceuticals Inc) and more on Quantisnow.